Antithrombotic strategy | Thromboembolism | ||
---|---|---|---|
Annual incidence rate | Adjusted HR (95% CI) | p-value | |
R2CHA2DS2-VA score ≥ 1 | |||
No anticoagulant | 1.86 | – | – |
Anticoagulant | 1.36 | 0.726 (0.483–1.090) | 0.122 |
R2CHA2DS2-VA score ≥ 2 | |||
No anticoagulant | 2.16 | – | – |
Anticoagulant | 1.38 | 0.630 (0.413–0.962) | 0.032 |